Often, Tirzepatide patients experience less nausea than Semaglutide patients
The scientific evidence base for DSIP is inconsistent, and no large-scale controlled human trials exist
Sea buckthorn seed oil reduces blood cholesterol and modulates gut microbiota
Semaglutide already shows protective effects against blood clots in high-risk patients, but smoking undermines this benefit
WEDNESDAY, July 22, 2026 (HealthDay News) -- Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market for compounded GLP-1 RA alternatives remains strong, and some of these products are from pharmacies with concerning regulatory histories, according to a study published online July 17 in JAMA Health Forum.Michael J
Mild AEs were infrequent: in Group 1 (liquid NAC rinse), 1/43 (2.3%) reported transient, nonspecific dizziness